CVE-2023-28528

CVE-2023-28528 is a high-severity vulnerability in Ibm Vios with a CVSS 3.x base score of 8.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

IBM AIX 7.1, 7.2, 7.3, and VIOS 3.1 could allow a non-privileged local user to exploit a vulnerability in the invscout command to execute arbitrary commands. IBM X-Force ID: 251207.

Frequently asked questions

What is CVE-2023-28528?
IBM AIX 7.1, 7.2, 7.3, and VIOS 3.1 could allow a non-privileged local user to exploit a vulnerability in the invscout command to execute arbitrary commands. IBM X-Force ID: 251207.
How severe is CVE-2023-28528?
CVE-2023-28528 has a CVSS 3.x base score of 8.4, rated high severity. It is exploitable over local access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-28528 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (70th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-28528?
CVE-2023-28528 primarily affects Ibm Vios. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-28528?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-28528 published?
CVE-2023-28528 was published on 2023-04-28 and last updated on 2026-06-17.

References

Affected products (4)

More vulnerabilities in Ibm Vios

All CVEs affecting Ibm Vios →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →